TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 51nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 95nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 26nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 21nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 29nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 21nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 6nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 22nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 6nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 7nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 21nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 19nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 398nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 20nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 175nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 4nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 159nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 7nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 32nMAssay Description:A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. The NL-RLuc ...More data for this Ligand-Target Pair